Greg Flynn Announced As Regional President Of Ashfield In The U.S.

Ashfield, part of UDG Healthcare plc, a global leader in commercialization services for the pharmaceutical and healthcare industry, announces the appointment of Greg Flynn as Regional President of Ashfield Commercial and Clinical businesses in the U.S.

Greg will oversee U.S. operations of Commercial, Clinical, Medical Information, Pharmacovigilance and Market Access. Greg is transitioning to this role from his prior position as Regional President in Japan and Representative Director of CMIC Ashfield.

Julian Tompkins, Global President for Ashfield Clinical and Commercial business said:  “We are delighted to have appointed Greg for this critical role in the U.S. business. His leadership in the Japanese market has yielded remarkable growth and proven his dedication to Ashfield’s success. With Greg’s innovative thinking and focus on people, we are looking forward to seeing his impact on the U.S. business.”

On his appointment, Greg said:  “Through the talent of our people and Ashfield’s commitment to helping improve lives, I have seen the power of what we do in this organization. The U.S. business has experienced phenomenal growth in the last 2 years and this new role is an exciting opportunity to carry on the growth. I am excited about the future of Ashfield in the U.S. and being part of the next phase in this company’s journey.”

Greg’s most recent experience was within Ashfield, establishing the joint venture of Ashfield in Japan, CMIC Ashfield. Over the course of five years, under Greg’s leadership, Ashfield went from a new player in the market to an industry leading partner, with over 650 staff across 44 clients.

Prior to this, Greg served as Head of CSO Operations for Ashfield in the U.K. and in the U.S. was Vice President of Operations. Greg’s earlier pharma career experience was with Takeda, where he progressed through several roles from account-level positions to Director.

Mick O’Leary, previously the Managing Director for Ashfield Ireland, has been appointed to take over Greg’s role in Japan. As Regional President for Ashfield Commercial and Clinical in Japan, Mick will lead CMIC Ashfield and support the group’s overall strategy of expansion in growth markets.

About Ashfield
Ashfield is a global leader in commercialization services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial and clinical services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies in over 50 countries.

For more information, visit www.ashfieldhealthcare.com

About UDG Healthcare plc
UDG Healthcare plc is a leading international partner of choice delivering commercial, clinical, communications and packaging services to the healthcare industry, employing over 8,000 people with operations in 23 countries and delivering services in over 50 countries. 

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.

Ashfield is a global leader in commercialization services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial and clinical services, and communications services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies in over 50 countries.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe.  Sharp is also a world leader in ’Track and Trace’ serialization services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

Aquilant is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.  For more information, visit www.udghealthcare.com.